Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) being developed for treating inflammatory diseases. It inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.
Molekulargewicht:
443.5
Reinheit:
99.42%
CAS Nummer:
[1800046-95-0]
Formel:
C23H25N9O
Target-Kategorie:
Syk
T11824LL
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten